3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
28
Carcinoma, Non-Small-Cell Lung
15
Squamous Cell Carcinoma of Head and Neck
14
Neoplasms
8
Colonic Neoplasms
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Rectal Neoplasms
5
Mouth Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma, Squamous Cell
4
Carcinoma
4
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Thyroid Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Soft Tissue Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Neurofibromatosis 2
1
Interventions
Oxaliplatin
8
Fluorouracil
8
Nivolumab
7
Leucovorin
7
Paclitaxel
6
Capecitabine
5
Taxes
4
Specimen Handling
4
pembrolizumab
3
Trastuzumab
3
Ramucirumab
3
Magnetic Resonance Spectroscopy
3
Cisplatin
3
zimberelimab
2
zanidatamab
2
Radiotherapy
2
Folfox protocol
2
Carboplatin
2
zolbetuximab
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tislelizumab
1
quemliclustat
1
obeticholic acid
1
futibatinib
1
dehydroftorafur
1
cixutumumab
1
balstilimab
1
Saline Solution
1
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Cetuximab
×
30 days
×
Clear all
No trials found.